UAMS treats a wide variety of spine and neurological conditions at the Jackson T. Stephens Spine & Neurosciences Institute including spinal and brain tumors, movement disorders, stroke, trigeminal neuralgia, brain metastases and spinal cord injuries.
In 2024, the American Heart Association and the American Stroke Association awarded UAMS its highest level of stroke recognition for the 10th consecutive year for providing stroke patients with the most advanced treatments, leading to the best outcomes.
As a Comprehensive Stroke Center designated by The Joint Commission, UAMS has a team of neurologists, vascular surgeons, neurosurgeons, cardiologists, neuroradiologists, rehabilitation specialists, and speech/swallowing specialists available to care for patients. UAMS Health is the first medical institution in Arkansas to join the National Institutes of Health StrokeNet, which makes new potential treatments available for patients with stroke and those at risk for stroke.
The UAMS Movement Disorders Clinic was one of the first six medical centers nationwide to be named a Comprehensive Care Center for Parkinson’s disease by the Parkinson’s Foundation in July 2022. The Movement Disorders program provides advanced care including deep brain stimulation electrode implantation and subsequent programming for patients with Parkinson’s disease, tremors, gait disturbances and other movement-related disorders. UAMS hosts an annual Parkinson’s Symposium and cooking, art and music classes for Parkinson’s patients.
The Arkansas Epilepsy Center at UAMS is the only Adult Level 4 comprehensive epilepsy center in Arkansas certified by the National Association of Epilepsy Centers. The center’s outpatient clinics, EEG laboratory, inpatient epilepsy-monitoring unit and surgical services provide multidisciplinary evaluation for patients with seizures and epilepsy.
In 2021, UAMS was designated a Center for Comprehensive MS Care by the National Multiple Sclerosis Society, recognizing UAMS’ knowledge and expertise in treating patients with the potentially disabling disease of the central nervous system.